<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>10</Volume><Issue>3</Issue></Journal><ArticleTitle>"Pharmacokinetic behavior of Amikacin in 31 Iranian critically ill septic patients "</ArticleTitle><FirstPage>111</FirstPage><LastPage>119</LastPage><AuthorList><Author><FirstName></FirstName><LastName>"Sabz Ghabaei AM</LastName></Author><Author><FirstName></FirstName><LastName>Mojtahed Zadeh M</LastName></Author><Author><FirstName></FirstName><LastName>Tajer Zadeh H</LastName></Author><Author><FirstName></FirstName><LastName>Asasi N</LastName></Author><Author><FirstName></FirstName><LastName>Ganji MR</LastName></Author><Author><FirstName></FirstName><LastName>Mohagheghi A</LastName></Author><Author><FirstName></FirstName><LastName>Gholami Kh</LastName></Author><Author><FirstName></FirstName><LastName>Hadavand N "</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>06</Day></PubDate></History><Abstract>The pharmacokinetic behavior of amikacin and predictive performance of Sawchuk-Zaske dosing method, have been prospectively evaluated in 31 (16 male, 15 female) critically ill septic patients of mean (±SD) age of 58±23 years, mean ideal body weight of 59.6±6.4 kg, mean creatinine clearance of 52±21.5 ml/min, mean serum albumin of 3.1±0.5 mg/dl and median APACHE (acute physiology and chronic health evaluation) II score of 26 (with a range of 18 to 33). In this cross-sectional study, critically ill patients who met the Bone criteria for spesis but had stable creatinine clearance (serum creatinine change</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/150</web_url><pdf_url>https://daru.tums.ac.ir/index.php/daru/article/download/150/150</pdf_url></Article></Articles>
